PeptiDream. has filed a patent for a new amino acid derivative that is expected to enhance the binding affinity of polypeptides containing the derivative. The derivative is selected from a group of amino acid derivatives. GlobalData’s report on PeptiDream gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on PeptiDream, Cyclosporin derivatives was a key innovation area identified from patents. PeptiDream's grant share as of September 2023 was 17%. Grant share is based on the ratio of number of grants to total number of patents.
A recently filed patent (Publication Number: US20230312479A1) describes amino acid derivatives and their enantiomers. The patent claims a group of amino acid derivatives, including compounds such as 2-[(3-acetamidopropyl)amino]acetic acid, 2-[(3-carbamoylpropyl)amino]acetic acid, and 2-[(3-methanesulfonylpropyl)amino]acetic acid, among others. These derivatives have potential applications in various fields, including pharmaceuticals and biotechnology.
The patent also mentions that the amino acid derivatives can have one or more functional groups protected by protecting groups. This protection helps in controlling the reactivity and stability of the derivatives, making them suitable for specific applications.
Furthermore, the patent claims the enantiomers of the amino acid derivatives mentioned in the previous claims. Enantiomers are mirror-image molecules that have the same chemical composition but differ in their spatial arrangement. The enantiomers of the amino acid derivatives described in the patent can have unique properties and may find applications in areas such as drug development and catalysis.
Overall, this patent presents a range of amino acid derivatives and their enantiomers, highlighting their potential applications in various fields. The protection of functional groups within the derivatives adds to their versatility and controllability. This patent may pave the way for the development of new drugs, biotechnological processes, and other applications that rely on amino acid derivatives and their enantiomers.
To know more about GlobalData’s detailed insights on PeptiDream, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.